期刊文献+

c-Myc基因在人非小细胞肺癌中的表达及基因沉默抑制H1299细胞效果的实验研究 被引量:7

The expression of c-Myc in non-small cell lung cancer and the effect of its silencing in inhibiting tumor cells
原文传递
导出
摘要 目的 :分析人非小细胞肺癌(non-small cell carcinoma,NSCLC)组织中c-Myc基因的表达,探讨沉默c-Myc基因在非小细胞肺癌基因治疗中的前景。方法:应用实时荧光定量PCR法检测84例非小细胞肺癌组织及其相应癌旁组织中c-Myc基因mRNA的表达情况。通过脂质体Lipofact AMINE2000将c-Myc基因siRNA瞬时转染至非小细胞肺癌H1299癌株细胞中,顺铂(Cisplatin,cis)药物毒性实验验证c-Myc基因沉默对肿瘤细胞的抑制效果。应用RT-PCR检测H1299细胞中c-Myc基因RNA的表达,CCK-8法检测抑制细胞的效果。结果 :非小细胞肺癌组织中c-Myc基因m RNA的表达水平高于相应的癌旁组织,差异有统计学意义(P<0.05)。c-Myc si RNA瞬时转染后的H1299细胞中,c-Myc基因m RNA的表达水平显著下降(P<0.05)。将c-Myc基因沉默和顺铂联合使用,还可以显著提高顺铂对H1299细胞增殖的抑制效果(P<0.05)。结论 :c-Myc基因在非小细胞肺癌组织中的表达水平明显高于相应癌旁组织,沉默c-Myc基因能显著提高顺铂抑制非小细胞肺癌H1299细胞增殖的作用,c-Myc基因有可能成为NSCLC基因治疗的新靶点。 Objective:To investigate the expression of c-Myc in non-small cell lung cancer(NSCLC)tissues,and to explore the prospects of the c-Myc gene silencing in NSCLC gene therapy. Methods:The expression levels of c-Myc mRNA in 84 NSCLC tissues and the corresponding para-cancerous tissues were detected by RFQ-PCR(real-time fluorescence quantitative-PCR). C-Myc siRNA was transfected into NSCLC H1299 cells by Lipofect AMINE 2000. Cisplatin toxicity experiments further validated effect of inhibiting tumor cells with c-Myc gene silencing. The expression level of c-Myc m RNA in H1299 cells was detected by RT-PCR,and the effect of inhibiting H1299 cells was detected by CCK-8(Cell Counting Kit-8). Results:The expression level of c-Myc m RNA in NSCLC tissues was higher than that in the corresponding para-cancerous tissues(P 0.05). C-Myc si RNA was successfully transfected into NSCLC H1299 cells. After transfection,the expression level of c-Myc mRNA was down-regulated in H1299 cells. Effect of inhibiting tumor cells increased significantly when the c-Myc gene silencing and cisplatin were in combination(P 0.05). Conclusion:The expression level of c-Myc m RNA in NSCLC tissues is higher than that in the corresponding para-cancerous tissues. The lower expression of c-Myc can significantly inhibit NSCLC H1299 cells. It is suggested that c-Myc may act as an oncogene in NSCLC gene therapy.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2016年第2期151-154,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省六大人才高峰(2012-WS-108)
关键词 非小细胞肺癌 基因治疗 C-MYC基因 non-small-cell lung carcinoma gene therapy c-Myc gene
  • 相关文献

参考文献11

  • 1Delgado MD,Leen J. Myc roles in hematopoiesis and leukemia[J]. Genes Cancer,2010,1 (6) :605-616.
  • 2Cavalheiro GR, Matos-Rodrigues GE, Gomes AL, et al. C- myc regulates cell proliferation during lens development. [J]. PLoS One,2014,9(2):e87182.
  • 3Rapp UR,Korn C,Ceteei F,et al. Mye is a metastasis gene for Non-Small-Cell lung eaneer[J]. PLoS One,2009,4 (6) : e6029.
  • 4Krysan K,Kusko R,Grogan T,et al. PGE2-driven expres- sion of e-Mye and oneomiR-17-92 contributes to apopto- sis resistanee in NSCLC[J]. Mol Cancer Res,2014,12 (5) :765-774.
  • 5Govindan R, Ding L, Griffith M, et al. Genomic landscape of non-small cell lung cancer in smokers and never smokers[J]. Ce11,2012,150(6): 1121-1134.
  • 6Reungwetwattana T, Dy GK. Targeted therapies in devel- opment for non-small eell lung cancer [J]. J Careinog, 2013.12(1) ,22.
  • 7Vachani A,Moon E,Wakeam E,et al. Gene therapy for lung neoplasms [J ]. Clin Chest Med, 2011,32 (4) : 865- 885.
  • 8Zarogoulidis P, Darwiche K, Sakkas A, et al. Suicide gene therapy for cancer-current strategies[J]. J Genet Syndr Gene Ther, 2013,4:16849.
  • 9Antonicelli A, Cafarotti S, Indini A, et al. EGFR-Targeted therapy for non-small cell lung cancer:Focus on EGFR oncogenic mutation[J]. Int J Med Sci, 2013,10(3) :320- 330.
  • 10Fridlender ZG,Sun J,Singhal S,et al. Chemotherapy deliv- ered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms [J]. Mol Ther, 2010, 18 ( 11 ) : 1947-1959.

同被引文献50

引证文献7

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部